Cancer BiologybioRxiv
A cell-based screen identifies HDAC inhibitors as activators of RIG-I signaling
E. Fraile-Bethencourt, M. H. Foss, D. Nelson…·S. Anand
The paper identifies HDAC inhibitors as activators of RIG-I signaling through a cell-based screen and shows their potential in enhancing immune responses in cancer.
DOI 10.3389/fmolb.2022.837610